NGL Fine Chem Ltd. — Investor Relations & Filings
NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 2025-03-25 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2025-03-19 | English | |
| Credit Rating | 2025-03-06 | English | |
| Updates | 2025-03-06 | English | |
| Action(s) taken or orders passed | 2025-02-25 | English | |
| Copy of Newspaper Publication | 2025-02-10 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
14 filings
| |||||
| 42414802 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-03-25 | English | ||
| 42389738 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-03-19 | English | ||
| 42406354 | Credit Rating | 2025-03-06 | English | ||
| 42406964 | Updates | 2025-03-06 | English | ||
| 42412451 | Action(s) taken or orders passed | 2025-02-25 | English | ||
| 42544544 | Copy of Newspaper Publication | 2025-02-10 | English | ||
| 42545048 | Investor Presentation | 2025-02-10 | English | ||
| 42557936 | Integrated Filing- Financial | 2025-02-07 | English | ||
| 42558530 | Financial Result Updates | 2025-02-07 | English | ||
| 42558549 | Outcome of Board Meeting | 2025-02-07 | English | ||
| 43980826 | Board Meeting — Financial Results | 2025-01-30 | English | ||
| 43980807 | Board Meeting — Board Meeting Intimation | 2025-01-30 | English | ||
| 42453036 | Action(s) initiated or orders passed | 2025-01-29 | English | ||
| 42457670 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-01-06 | English | ||
|
2024
1 filing
| |||||
| 42444971 | Trading Window | 2024-12-25 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NGL Fine Chem Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62500/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62500 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62500 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62500 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62500}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NGL Fine Chem Ltd. (id: 62500)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.